Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Histamine-Controlled, Phase 3 Study to Determine the Safety and Efficacy of Bee Venom in the Treatment of Knee Osteoarthritis

NCT00253942 is registered in ClinicalTrials.gov with Rheumatology Therapeutics Medical Center as lead sponsor.

NCT NCT00253942
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00253942 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Histamine-Controlled, Phase 3 Study to Determine the Safety and Efficacy of Bee Venom in the Treatment of Knee Osteoarthritis
Lead sponsor
Rheumatology Therapeutics Medical Center
Phase
Phase 3
Overall status
Unknown status
Start date
November 30, 2005
Completion date
Not reported
Enrollment
40
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

persons with mild to moderate knee osteoarthritis